<!DOCTYPE html>
<html lang="en">

<head>
	<meta charset="utf-8"/>
	<title>Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication</title>
	<meta name="viewport" content="width=device-width, initial-scale=1.0">
	
    <!-- Customized Bootstrap + Font Awesome + Solarized -->
    <link href="/css/style.css" rel="stylesheet" media="screen">

	<!-- Favicon -->
	<link rel="shortcut icon" href="/images/favicon.png"/>	
		
	<!-- Typekit -->
	<!-- <script>
		(function(d) {
			var config = {
			kitId: 'xeu8jut',
			scriptTimeout: 3000
			},
			h=d.documentElement,t=setTimeout(function(){h.className=h.className.replace(/\bwf-loading\b/g,"")+" wf-inactive";},config.scriptTimeout),tk=d.createElement("script"),f=false,s=d.getElementsByTagName("script")[0],a;h.className+=" wf-loading";tk.src='//use.typekit.net/'+config.kitId+'.js';tk.async=true;tk.onload=tk.onreadystatechange=function(){a=this.readyState;if(f||a&&a!="complete"&&a!="loaded")return;f=true;clearTimeout(t);try{Typekit.load(config)}catch(e){}};s.parentNode.insertBefore(tk,s)
		})(document);
	</script> -->


	<!-- Google Analytics -->	
	<script>
		(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
		(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
		m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
		})(window,document,'script','//www.google-analytics.com/analytics.js','ga');

		ga('create', 'UA-58618307-1', 'cole-trapnell-lab.github.io');
		ga('send', 'pageview');

	</script>

	<!-- Bootstrap -->
	<script src="/js/bootstrap.min.js"></script>
			
</head>

<body>

	<div id="header">
		<nav class="navbar navbar-expand-md navbar-light bg-navbar">
			<div class="container">
				
				<a class="navbar-brand" href="/">
					<img class="logo navbar-brand d-inline-block align-top ml-0 mr-1" src="/images/logo.svg">
					Trapnell lab
				</a>
				
				<button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation">
					<span class="navbar-toggler-icon"></span>
				</button>
				<div class="collapse navbar-collapse" id="navbarNav">
					<ul class="navbar-nav nav-pills ml-auto">
						
						<li class="nav-link active">
						
						<a class="mx-1" href="/papers/">Papers</a>
						</li>
						
						<li class="nav-link">
						
						<a class="mx-1" href="/projects/">Projects</a></li>
						
						<li class="nav-link">
						
						<a class="mx-1" href="/team/">Team</a></li>
					</ul>
				</div>
			</div>
		</nav>
	</div>

	<div class="container mt-4">

	<div class="bigspacer"></div>

<div class="row">
	<div class="col-md-12">
		<div class="media">
			
			<img class="pull-left pad-right media-object" src="/images/papers/vanderwall-ae-rhino-sars.png" style="max-width:150px">
			
			<div class="media-body">
				<div class="title media-heading">
					Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication
				</div>
				<p>
				<div class="smallhead">
					Elizabeth R Vanderwall, Kaitlyn A Barrow, Lucille M Rich, David F Read, Cole Trapnell, Oghenemega Okoloko, Steven F Ziegler, Teal S Hallstrand, Maria P White, Jason S Debley
					<br>

          </div>
					<div class="bigspacer"></div>
                <div class="smallhead">
					Scientific Reports
					(2022)
				</div>
			</div>
		</div>
	</div>
</div>

<div class="bigspacer"></div>

<div class="row">
	<div class="col-md-3">
		<div class="bigspacer"></div>
		<div class="glyphbox note">
			
			<div class="smallhead">
				PDF
			</div>
			<div class="pad-left note">
				<div class="smallspacer"></div>
				<i class="fa fa-file-text-o fa-fw"></i>
				<a class="off" href="/pdfs/papers/vanderwall-ae-rhino-sars.pdf">vanderwall-ae-rhino-sars.pdf</a>
			</div>
			<div class="bigspacer"></div>
			
			
			
			
			<div class="smallhead">
				DOI
			</div>
			<div class="pad-left note">
				<div class="smallspacer"></div>
				<i class="fa fa-external-link fa-fw"></i>
				<a class="off" href="http://dx.doi.org/10.1038/s41598-022-10763-2">10.1038/s41598-022-10763-2</a>
			</div>
			<div class="bigspacer"></div>
			
			
			<div class="smallhead">
				Share
			</div>
<!-- 			<div class="pad-left note">
				<div class="smallspacer"></div>
				<i class="fa fa-twitter fa-fw"></i> <a class="off" href="http://twitter.com/share?url=http://bedford.io/papers/vanderwall-ae-rhino-sars/&text=Airway%20epithelial%20interferon%20response%20to%20SARS-CoV-2%20is%20inferior%20to%20rhinovirus%20and%20heterologous%20rhinovirus%20infection%20suppresses%20SARS-CoV-2%20replication" target="_blank">tweet</a>
				
			</div>		 -->
			</div>
	</div>
	<div class="col-md-8">
		<div class="post">
			<h1 id="abstract">Abstract</h1>

<p>Common alphacoronaviruses and human rhinoviruses (HRV) induce type I and III interferon (IFN) responses important to limiting viral replication in the airway epithelium. In contrast, highly pathogenic betacoronaviruses including SARS-CoV-2 may evade or antagonize RNA-induced IFN I/III responses. In airway epithelial cells (AECs) from children and older adults we compared IFN I/III responses to SARS-CoV-2 and HRV-16, and assessed whether pre-infection with HRV-16, or pretreatment with recombinant IFN-β or IFN-λ, modified SARS-CoV-2 replication. Bronchial AECs from children (ages 6–18 years) and older adults (ages 60–75 years) were differentiated ex vivo to generate organotypic cultures. In a biosafety level 3 (BSL-3) facility, cultures were infected with SARS-CoV-2 or HRV-16, and RNA and protein was harvested from cell lysates 96 h. following infection and supernatant was collected 48 and 96 h. following infection. In additional experiments cultures were pre-infected with HRV-16, or pre-treated with recombinant IFN-β1 or IFN-λ2 before SARS-CoV-2 infection. In a subset of experiments a range of infectious concentrations of HRV-16, SARS-CoV-2 WA-01, SARS-CoV-2 Delta variant, and SARS-CoV-2 Omicron variant were studied. Despite significant between-donor heterogeneity SARS-CoV-2 replicated 100 times more efficiently than HRV-16. IFNB1, INFL2, and CXCL10 gene expression and protein production following HRV-16 infection was significantly greater than following SARS-CoV-2. IFN gene expression and protein production were inversely correlated with SARS-CoV-2 replication. Treatment of cultures with recombinant IFNβ1 or IFNλ2, or pre-infection of cultures with HRV-16, markedly reduced SARS-CoV-2 replication. In addition to marked between-donor heterogeneity in IFN responses and viral replication, SARS-CoV-2 (WA-01, Delta, and Omicron variants) elicits a less robust IFN response in primary AEC cultures than does rhinovirus, and heterologous rhinovirus infection, or treatment with recombinant IFN-β1 or IFN-λ2, reduces SARS-CoV-2 replication, although to a lesser degree for the Delta and Omicron variants.</p>

<p>** corresponding authors</p>

		</div>
	</div>
	<div class="col-md-1"></div>
</div>


	</div>

	<div id="footer"><span style="display:none">foo</span></div>

</body>
</html>

